Clinical Trial Update: Protective Effect of Mangafodipir Against Oxaliplatin Neurotoxicity [Phase 2]

View source ↗

Summary

Phase 2 trial assessing whether Mangafodipir can protect cancer patients from oxaliplatin-induced neurotoxicity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Mangafodipir (Mangafodipir trisodium)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Neurotoxic Disorders, Cancer | Phase 2 | Status: COMPLETED